Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche's CEA (carcinoembryonic antigen assay) products "breach Immunomedics' EU patent"

This article was originally published in Clinica

Executive Summary

An appeals court in the Netherlands ruled on June 27 that Roche's sale of carcinoembryonic antigen assay (CEA) kits in Europe infringe two European patents held by US company Immunomedics. CEA is one of the most widely used markers for colorectal and other cancers, said Morris Plains, New Jersey-based Immunomedics, as it welcomed the outcome of the latest round of patent infringement claims involving itself and Roche.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT067262

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel